Preoperatively irradiated rectal carcinoma: Analysis of the histopathologic response and predictive value of proliferating cell nuclear antigen immunostaining

Oncology

Volumn 64, Issue 3, 2003, Pages 213-219

  Diez M ^a   Ramos, P ^a   Medrano, M J ^b   Muguerza J M ^a   Villeta, R ^a   Lozano, O ^a   Escribano, J ^a   Noguerales, F ^a   Ruiz A ^a   Granell, J ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b CARLOS III INSTITUTE OF HEALTH   (Spain)

Author keywords

p53 protein; Proliferating cell nuclear antigen; Radiotherapy; Rectal neoplasm

Indexed keywords

CYCLINE; FOLINIC ACID; PROTEIN P53; PYRIMIDINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER CYTODIAGNOSIS; CANCER GRADING; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RISK; CANCER SURGERY; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PREDICTION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTOSCOPY; RECTUM CARCINOMA; STROMA; TUMOR BIOPSY;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROLIFERATING CELL NUCLEAR ANTIGEN; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0345700735     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000069307     Document Type: Article

References (26)

1. Abulafi AM, Williams NS: Local recurrence of colorectal cancer: The problem, mechanisms, management and adjuvant therapy. Br J Surg 1994;81:7-9.
2. Marks G, Mohiuddin M, Masoni L: The reality of radical sphincter preservation surgery for cancer of the distal 3 cm of the rectum following high-dose radiation. Int J Radiat Oncol Biol Phys 1993;27:779-783.
3. Stryker SJ, Krystyna DK, Rademaker A, Shaw JM, Ujiki G, Poticha SM: Preoperative 'chemoradiation' for stages II and III rectal carcinoma. Arch Surg 1996;131:514-519.
4. Minsky BC, Cohen A, Enker W, Kelsen D, Kemeny N, Ilson D, Guillen J, Saltz L, Frankel D, Conti J: Preoperative 5-fluorouracil, low dose leucovorin and concurrent radiation therapy for rectal cancer. Cancer 1994;73:273-278.
5. Burke SJ, Percarpio BA, Knight DC, Kwasnisk EM: Combined preoperative radiation and mitomycin/5-fluorouracil treatment for locally advanced rectal adenocarcinoma. J Am Coll Surg 1998;187:164-170.
6. Wheeler JMD, Warren BF, Jones AC, Mortensen NJ: Preoperative radiotherapy for rectal cancer: Implications for surgeons, pathologists and radiologists. Br J Surg 1999;86:1108-1120.
7. Velculescu V, El-Deiry W: Biological and clinical importance of the p53 tumor suppressor gene. Clin Chem 1996;42:858-868.
8. Chang F, Syrjänen S, Syrjänen K: Implications of the p53 tumor-suppressor gene in clinical oncology. J Clin Oncol 1995;13:1009-1022.
9. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T: p53 is required for radiation induced apoptosis in mouse thymocytes. Nature 1993;362:847-849.
10. Lowe S, Ruley H, Jacks T, Housman T: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993;362:847-849.
11. McIlwrath AJ, Vasey PA, Ross GM, Brown R: Cell cycle arrests and radiosensitivity of human tumor cell lines: Dependence on wild-type p53 for radiosensitivity. Cancer Res 1994;54:3718-3722.
12. Fan S, El-Deiry WS, Bae I, Freeman J, Jondle D, Bhatia K, Fornace AJ, Magrath I, Kohn KW, O'Connor PM: p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res 1994;54:5824-5830.
13. Dworak O, Keilholz L, Hoffman A: Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997;12:19-23.
14. Spitz F, Giacco G, Hess K, Larry L, Rich A, Janjan N, Clearly K, Skibber J: p53 immunohistochemical staining predicts residual disease after chemoradiation in patients with high risk rectal cancer. Clin Cancer Res 1997;3:1685-1690.
15. Darnton SJ, Allen SM, Edwards CW, Matthews HR: Histopathological findings in oesophageal carcinoma with and without preoperative chemotherapy. J Clin Pathol 1993;46:51-55.
16. Mandard A, Dalibard F, Mandard JC, Marnay J, Amar MH, Petiot JF, Roussel A, Jacob JH, Segol P, Samana G, Ollivier JO, Bonvalot S, Gignoux M: Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Cancer 1994;73:2680-2686.
17. Scott N, Hale A, Deakin M, Hand P, Adab FA, Hall C, Williams GT, Elder JB: A histopathological assessment of the response of rectal adenocarcinoma to combination chemo-radiotherapy: Relationship to apoptotic activity, p53 and bcl-2 expression. Eur J Surg Oncol 1998;24:169-173.
18. Yamaguchi A, Nakagawara G, Kurosaka Y, Nishimura G, Yonemura Y, Miyazaki I: p53 immunoreaction in endoscopic biopsy specimens of colorectal cancer, and its prognostic significance. Br J Cancer 1993;68:399-402.
19. Desai GR, Myerson RJ, Higashikubo R, Binbaum E, Fleshman J, Fry R, Kodner I, Kucik N, Lacey D, Ribeiro M: Carcinoma of the rectum. Possible cellular predictors of metastatic potential and response to radiation therapy. Dis Colon Rectum 1996;39:1090-1096.
20. Adell G, Sun XF, Stal O, Klintenberg C, Sjodahl R, Nordenskjold B: p53 status: An indicator for the effect of preoperative radiotherapy of rectal cancer. Radiother Oncol 1999;51:169-174.
21. Qiu H, Sirivongs P, Rothenberger M, Rothenberger DA, García-Aguilar J: Molecular prognostic factors in rectal cancer treated by radiation and surgery. Dis Colon Rectum 2000;43:451-459.
22. Midgley CA, Owens B, Briscoe CV, Thomas D, Lane DP, Hall PA: Coupling between gamma irradiation, p53 induction and the apoptotic response depends upon cell type in vivo. J Cell Sci 1995;108:1843-1848.
23. Bracey TS, Miller JC, Preece A, Paraskeva C: Radiation induced apoptosis in human colorectal adenoma and carcinoma cell lines can occur in the absence of wild-type p53. Oncogene 1995;10:2391-2396.
24. Choi HJ, Jung IK, Kim SS, Hong SH: Proliferating cell nuclear antigen expression and its relationship to malignancy potential in invasive colorectal carcinomas. Dis Colon Rectum 1997;40:51-59.
25. Willett C, Warland G, Cheek R, Coen J, Efird J, Shellito P, Compton C: Proliferating cell nuclear antigen and mitotic activity in rectal cancer: Predictor of response to preoperative irradiation. J Clin Oncol 1994;12:679-682.
26. Willett CG, Hagan M, Daley W, Warland G, Shellito P, Compton C: Changes in tumor proliferation of rectal cancer induced by preoperative 5-fluorouracil. Dis Colon Rectum 1998;41:62-67.